Jonathan Goodman, MPhil

Jonathan was the editor of Cancer Therapy Advisor from 2016 to 2018. His work has appeared in Aeon Magazine, The Week, and The Guardian, among other publications.

All articles by Jonathan Goodman, MPhil

Lung Cancer

Lurbinectedin Plus Doxorubicin Improves PFS, Not OS, in Small-Cell Lung Cancer

Jonathan Goodman, MPhil

October 4, 2021

The 12-month progression-free survival rate was superior in the lurbinectedin arm.

Lung Cancer

Adding Immunotherapy to Chemo Improves Survival in Metastatic Non-Small Cell Lung Cancer

Jonathan Goodman, MPhil

September 24, 2021

The combinations conferred benefits in nonsquamous non-small cell lung cancer only.

Lung Cancer

Lung Cancer Patients Have Lower Antibody Response to COVID-19 Vaccination

Jonathan Goodman, MPhil

September 20, 2021

Researchers are evaluating whether specific anticancer therapies affect antibody levels.

General Pulmonology

Thrombotic Events Linked With Higher Mortality Among Pediatric Patients Hospitalized With COVID-19, MIS-C

Jonathan Goodman, MPhil

September 9, 2021

Researchers sought to determine the mortality rate for pediatric patients with COVID-19 or multisystem inflammatory syndrome in children who experience thrombotic events.